TY - JOUR
T1 - A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma
AU - Stringer, Brett W.
AU - Day, Bryan W.
AU - D’Souza, Rochelle C.J.
AU - Jamieson, Paul R.
AU - Ensbey, Kathleen S.
AU - Bruce, Zara C.
AU - Lim, Yi Chieh
AU - Goasdoué, Kate
AU - Offenhäuser, Carolin
AU - Akgül, Seçkin
AU - Allan, Suzanne
AU - Robertson, Thomas
AU - Lucas, Peter
AU - Tollesson, Gert
AU - Campbell, Scott
AU - Winter, Craig
AU - Do, Hongdo
AU - Dobrovic, Alexander
AU - Inglis, Po Ling
AU - Jeffree, Rosalind L.
AU - Johns, Terrance G.
AU - Boyd, Andrew W.
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Low-passage, serum-free cell lines cultured from patient tumour tissue are the gold-standard for preclinical studies and cellular investigations of glioblastoma (GBM) biology, yet entrenched, poorly-representative cell line models are still widely used, compromising the significance of much GBM research. We submit that greater adoption of these critical resources will be promoted by the provision of a suitably-sized, meaningfully-described reference collection along with appropriate tools for working with them. Consequently, we present a curated panel of 12 readily-usable, genetically-diverse, tumourigenic, patient-derived, low-passage, serum-free cell lines representing the spectrum of molecular subtypes of IDH-wildtype GBM along with their detailed phenotypic characterisation plus a bespoke set of lentiviral plasmids for bioluminescent/fluorescent labelling, gene expression and CRISPR/Cas9-mediated gene inactivation. The cell lines and all accompanying data are readily-accessible via a single website, Q-Cell (qimrberghofer.edu.au/q-cell/) and all plasmids are available from Addgene. These resources should prove valuable to investigators seeking readily-usable, well-characterised, clinically-relevant, gold-standard models of GBM.
AB - Low-passage, serum-free cell lines cultured from patient tumour tissue are the gold-standard for preclinical studies and cellular investigations of glioblastoma (GBM) biology, yet entrenched, poorly-representative cell line models are still widely used, compromising the significance of much GBM research. We submit that greater adoption of these critical resources will be promoted by the provision of a suitably-sized, meaningfully-described reference collection along with appropriate tools for working with them. Consequently, we present a curated panel of 12 readily-usable, genetically-diverse, tumourigenic, patient-derived, low-passage, serum-free cell lines representing the spectrum of molecular subtypes of IDH-wildtype GBM along with their detailed phenotypic characterisation plus a bespoke set of lentiviral plasmids for bioluminescent/fluorescent labelling, gene expression and CRISPR/Cas9-mediated gene inactivation. The cell lines and all accompanying data are readily-accessible via a single website, Q-Cell (qimrberghofer.edu.au/q-cell/) and all plasmids are available from Addgene. These resources should prove valuable to investigators seeking readily-usable, well-characterised, clinically-relevant, gold-standard models of GBM.
UR - http://www.scopus.com/inward/record.url?scp=85063328349&partnerID=8YFLogxK
U2 - 10.1038/s41598-019-41277-z
DO - 10.1038/s41598-019-41277-z
M3 - Article
C2 - 30894629
AN - SCOPUS:85063328349
SN - 2045-2322
VL - 9
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 4902
ER -